Ours Privacy provides a HIPAA‑compliant customer data platform that de‑identifies and routes patient data before it reaches third‑party marketing and analytics tools. By integrating with platforms such as Google Ads, GA4, Meta, and tag managers, it enables healthcare marketers to run optimized campaigns without exposing protected health information, while maintaining US‑hosted infrastructure, signed BAAs, and SOC 2 Type II compliance.
Funding
Funding not disclosed
2OFounders
Product
Problem
Healthcare marketers must use digital advertising and analytics tools to reach patients, but these tools often collect or transmit protected health information (PHI), exposing organizations to HIPAA violations and costly lawsuits. Existing solutions either lack proper compliance safeguards or require complex workarounds that limit the use of best‑in‑class marketing platforms.
Solution
Ours Privacy offers a HIPAA‑compliant customer data platform (CDP) that de‑identifies and routes patient data before it reaches third‑party marketing and analytics services. The platform integrates with common tools such as Tag Management, Google Analytics 4, Google Ads, Meta, and others, allowing marketers to run optimized campaigns without exposing PHI. All data processing occurs on US‑hosted infrastructure under signed Business Associate Agreements (BAAs) and SOC 2 Type II certification, ensuring regulatory compliance. By handling de‑identification centrally, Ours Privacy eliminates hidden trackers and reduces the risk of privacy breaches while preserving the full functionality of performance‑marketing workflows.
Target Audience
Primary customers are healthcare organizations, hospitals, and pharmaceutical marketers that need to run digital advertising and analytics campaigns while remaining fully HIPAA‑compliant.
Features
- Centralized CDP that ingests, stores, and de‑identifies patient data before forwarding to marketing and analytics vendors
- Pre‑built integrations with major ad and analytics platforms (Google Ads, GA4, Meta, Tag Management, etc.)
- Signed BAAs and SOC 2 Type II compliance, with all services hosted in the United States
- Automatic removal of PHI from tracking pixels and scripts to prevent exposure of IP addresses, browsing behavior, and other sensitive information
- No AI model training on raw patient data, ensuring data is never used for unintended machine‑learning purposes
- Real‑time privacy controls that let marketers activate or pause data sharing per campaign or regulatory requirement